Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:47:25 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Entheon Biomedical Corp
Symbol ENBI
Shares Issued 59,089,266
Close 2023-07-31 C$ 0.025
Market Cap C$ 1,477,232
Recent Sedar+ Documents

Entheon terminates chief science officer Hegle

2023-07-31 16:31 ET - News Release

Subject: Entheon Biomedical - July 31 NR Word Document File: '\\swfile\EmailIn\20230731 131452 Attachment 2023_07_31 ENBI NR Change of Officers.docx' Entheon Biomedical Announces Change of Officers VANCOUVER, BC, July 31, 2023 - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company") announces that the Company has terminated Andrew Hegle's position as Chief Science Officer, effective today. Mr. Hegle will continue on the Company's Board of Directors. About Entheon Biomedical Corp. Entheon is a biotechnology research and development company interested in treating addiction and substance use disorders. On Behalf of the Board of Directors, Timothy Ko, CEO, President and Director For more information, please contact the Company at: Entheon Biomedical Corp. Timothy Ko, CEO timothy@entheonbiomedical.com https://entheonbiomedical.com

© 2026 Canjex Publishing Ltd. All rights reserved.